Literature DB >> 26892251

Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2015-Part 2 of 2: Myocardial perfusion imaging.

Fadi G Hage1,2, Wael A AlJaroudi3.   

Abstract

In 2015, the Journal of Nuclear Cardiology (®) published many high-quality articles. In this series, we will summarize key articles that have appeared in the Journal last year to provide for the interested reader a quick review of the advancements that have recently occurred in the field. In the first article of this 2-part series, we concentrated on publications dealing with plaque imaging, cardiac positron emission tomography, computed tomography, and magnetic resonance. This review will focus on myocardial perfusion imaging summarizing advances in the field including in diagnosis, prognosis, and appropriate use.

Keywords:  Myocardial perfusion imaging; SPECT; appropriateness; dyssynchrony; phase analysis; regadenoson; safety

Mesh:

Year:  2016        PMID: 26892251     DOI: 10.1007/s12350-016-0444-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  39 in total

1.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

2.  Contemporary relevance of TID: Based on the company it keeps.

Authors:  Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

3.  Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients.

Authors:  Stephanie El-Hajj; Wael A AlJaroudi; Ayman Farag; Steven Bleich; Padma Manaoragada; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-05-28       Impact factor: 5.952

4.  Prognostic significance of ischemia location on stress myocardial perfusion SPECT: Tracing the fingerprints of the widow maker.

Authors:  Abdou Elhendy
Journal:  J Nucl Cardiol       Date:  2015-04-02       Impact factor: 5.952

5.  Myocardial perfusion imaging determination using an appropriate use smartphone application.

Authors:  Ashish Mahajan; Susan Bal; Harvey Hahn
Journal:  J Nucl Cardiol       Date:  2014-10-02       Impact factor: 5.952

6.  Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.

Authors:  Angela S Koh; Fei Gao; C T Chin; Felix Y J Keng; Ru-San Tan; Terrance S J Chua
Journal:  J Nucl Cardiol       Date:  2015-09-11       Impact factor: 5.952

7.  A blunted heart rate response to regadenoson is an independent prognostic indicator in patients undergoing myocardial perfusion imaging.

Authors:  Fadi G Hage; Phillip Dean; Fahad Iqbal; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-07-22       Impact factor: 5.952

8.  The prognostic value of regadenoson myocardial perfusion imaging.

Authors:  Fadi G Hage; Gopal Ghimire; Davis Lester; Joshua Mckay; Steven Bleich; Stephanie El-Hajj; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2015-02-14       Impact factor: 5.952

9.  Comparison of the diagnostic accuracies of very low stress-dose with standard-dose myocardial perfusion imaging: Automated quantification of one-day, stress-first SPECT using a CZT camera.

Authors:  Tali Sharir; Marina Pinskiy; Abraham Pardes; Arik Rochman; Vitali Prokhorov; Gil Kovalski; Konstantine Merzon; Andrzej Bojko; Boris Brodkin
Journal:  J Nucl Cardiol       Date:  2015-05-27       Impact factor: 5.952

10.  Appropriate use criteria for SPECT myocardial perfusion imaging: Are they appropriate for women?

Authors:  Rami Doukky; Kathleen Hayes; Nathan Frogge
Journal:  J Nucl Cardiol       Date:  2015-08-25       Impact factor: 5.952

View more
  5 in total

Review 1.  Review of Cardiovascular Imaging in the Journal of Nuclear Cardiology in 2016. Part 1 of 2: Positron Emission Tomography, Computed Tomography and Magnetic Resonance.

Authors:  Wael AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-02-13       Impact factor: 5.952

2.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2019-01-02       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

Review 4.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology in 2017. Part 2 of 2: Myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2018-04-16       Impact factor: 5.952

Review 5.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.